Our studies showing the critical role of interactions among BER proteins suggest that these protein-protein interactions, typically involving a common binding interface, as in NEIL1, should be explored as a target to enhance chemo/radiation sensitivity of cancer cells. The gene discussed is NEIL1; the disease is cancer.